Crossmark

Evaluation of serum TWEAK levels and treatment response in psoriasis and psoriatic arthritis: a prospective comparative case–control study of adalimumab and methotrexate

Crossref DOI link: https://doi.org/10.1007/s10067-026-07981-8

Published Online: 2026-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hegazy, Eisa M. https://orcid.org/0000-0001-8638-0427
Sadek, Eslam Abdelfattah

Ahmed, Shimaa Saber
Funding

Funding for this research was provided by:

South Valley University
License Information

Text and Data Mining valid from 2026-03-18

Version of Record valid from 2026-03-18
More Information

Article History

Received: 6 November 2025

Revised: 1 February 2026

Accepted: 2 February 2026

First Online: 18 March 2026

Compliance with ethical standards

:

: Approved by institutional review board (Approval No. DVA021/4/204/4/844).

: Written informed consent was obtained from all participants.

: Obtained from participants.

: None.

Document is current

Any future updates will be listed below